Document:

QuickLinks
 -- Click here to rapidly navigate through this document

Exhibit 10.33  

 
 

RECAPITALIZATION AGREEMENT    
    

BY AND AMONG  

 JAZZ SEMICONDUCTOR, INC.,  

 CARLYLE PARTNERS III, L.P.,  

 CP III COINVESTMENT, L.P.,  

 CARLYLE HIGH YIELD PARTNERS, L.P.  

 AND  

 CONEXANT SYSTEMS, INC.  

 DATED AS OF JULY 30, 2002  

 
TABLE OF CONTENTS  

	 
	 	 
	 	 
	 	Page

	1.	 	Definitions.	 	1
	

2.	
 	

Recapitalization.	
 	

2
	

 	
 	

2.1	
 	

Authorization of Shares	
 	

2
	 	 	2.2	 	Recapitalization	 	2
	 	 	2.3	 	Tax Free Reorganization	 	2
	

3.	
 	

Closing and Delivery.	
 	

2
	

 	
 	

3.1	
 	

Closing	
 	

2
	 	 	3.2	 	Delivery	 	3
	

4.	
 	

Representations and Warranties of the Stockholders.	
 	

3
	

 	
 	

4.1	
 	

Requisite Power; Authorization; Binding Obligations	
 	

3
	 	 	4.2	 	Investment Representations	 	3
	 	 	4.3	 	Transfer Restrictions	 	4
	 	 	4.4	 	Ownership of Shares of Common Stock	 	4
	

5.	
 	

Representations and Warranties of the Company.	
 	

4
	

 	
 	

5.1	
 	

Requisite Power; Authorization; Binding Obligations.	
 	

4
	 	 	5.2	 	Valid Issuance.	 	4
	

6.	
 	

Conditions to Closing	
 	

4
	

 	
 	

6.1	
 	

Conditions to Obligation of Each Stockholder	
 	

4
	 	 	6.2	 	Conditions to Obligations of the Company	 	5
	

7.	
 	

Miscellaneous	
 	

5
	

 	
 	

7.1	
 	

Governing Law	
 	

5
	 	 	7.2	 	Survival	 	5
	 	 	7.3	 	Successors and Assigns; Assignment	 	5
	 	 	7.4	 	Entire Agreement	 	6
	 	 	7.5	 	Severability	 	6
	 	 	7.6	 	Amendment	 	6
	 	 	7.7	 	Waiver.	 	6
	 	 	7.8	 	Notices	 	6
	 	 	7.9	 	Remedies Cumulative; Specific Performance	 	7
	 	 	7.10	 	Further Assurances.	 	7
	 	 	7.11	 	Termination	 	7
	 	 	7.12	 	Construction; Interpretation	 	7
	 	 	7.13	 	Counterparts	 	7

i

 
INDEX OF EXHIBITS  

	Exhibit A	 	Recapitalization Allocation
	Exhibit B	 	Restated Certificate of Incorporation
	Exhibit C	 	Amended and Restated Stockholder Agreement
	Exhibit D	 	Amended and Restated Registration Rights Agreement
	Exhibit E	 	Amended and Restated Carlyle Board Representation Agreement
	Exhibit F	 	Amended and Restated Conexant Board Representation Agreement

ii

JAZZ SEMICONDUCTOR, INC.

RECAPITALIZATION AGREEMENT  

        THIS RECAPITALIZATION AGREEMENT (the "Agreement") is entered into
as of July 30, 2002 by and among JAZZ SEMICONDUCTOR, INC., a Delaware corporation (the
"Company"), Carlyle Partners III, L.P., a Delaware limited partnership, CP III Coinvestment, L.P., a Delaware limited partnership, Carlyle High Yield
Partners, L.P. a Delaware limited partnership (each a "Carlyle Entity" and, collectively, the "Carlyle
Entities") and Conexant Systems, Inc., a Delaware corporation ("Conexant" and, together with the Carlyle Entities, the
"Stockholders"). 

RECITALS  

        WHEREAS, as of the date hereof, Carlyle owns of record and beneficially 5,500,000 shares of the Class A
Common Stock, $0.001 par value, of the Company (the "Class A Common Stock"), and Conexant owns of record and beneficially 4,500,000 shares of the
Class B Common Stock, $0.001 par value, of the Company (the "Class B Common Stock" and, together with the Class A Common Stock, the
"Common Stock"); and 

        WHEREAS, the Company and each Stockholder believe it is in the best interest of the Company and each Stockholder to effect a
recapitalization of the Company (the "Recapitalization") pursuant to which the Carlyle Entities' shares of Class A Common Stock are to be
exchanged for shares of the Series A Preferred Stock, $0.001 par value, of the Company (the "Series A Preferred Stock"), and Conexant's
shares of Class B Common Stock are to be exchanged for shares of the Series B Preferred Stock, $0.001 par value, of the Company (the "Series B Preferred
Stock," and, together with the Series A Preferred Stock, the "Designated Preferred Stock"). 

        NOW, THEREFORE, in consideration of the foregoing recitals and the mutual promises hereinafter set forth, and intending to be legally
bound thereby, the parties hereto agree as follows: 

1.     Definitions.  

        The following terms used in this Agreement shall have the following meanings (unless otherwise expressly provided herein): 

        "Affiliate," with respect to any Person or Stockholder, shall mean any other Person or Stockholder directly or indirectly controlling,
controlled by or under common control with, such Person or Stockholder. For purposes of this Agreement, "control" (including with correlative meanings,
the terms "controlling", "controlled by" or "under common control
with") as used with respect to any Person or Stockholder, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management and
policies of such Person or Stockholder, whether through the ownership of voting securities or by contract or otherwise. 

        "Board of Directors" shall mean the Board of Directors of the Company. 

        "Capital Stock" shall mean, with respect to any Person, any and all shares, interests, participations or other equivalents (however
designated, whether voting or non-voting) of such Person's capital stock or other equity interests, including, without limitation, common stock, preferred stock, partnership interests and
limited liability company interests, whether now outstanding or issued after the date hereof. 

        "Entity" shall mean any corporation (including any non-profit corporation), general partnership, limited partnership, limited
liability partnership, joint venture, estate, trust, cooperative, foundation, society, political party, union, company (including any limited liability company or joint stock company), firm or other
enterprise, association, organization or entity. 

        "Governmental Body" shall mean any: (a) nation, principality, state, commonwealth, province, territory, county, municipality,
district or other jurisdiction; (b) federal, state, local, municipal or foreign government (including any agency, department, bureau, division, or other administrative body thereof); or
(c) governmental or quasi-governmental authority of any nature. 

 

        "Person" shall mean any individual, Entity or Governmental Body. 

        "Proceeding" shall mean any action, suit, litigation, arbitration, or investigation (including any civil, criminal or administrative)
commenced, brought, conducted or heard by or before, or otherwise involving, any Governmental Body or any arbitrator or arbitration panel. 

        "Stockholder Representatives" shall mean those natural Persons appointed to the Board of Directors by the Stockholders as their respective
agents to manage the business and affairs of the Company. 

        "Subsidiary" shall mean, in respect of any Person, any Entity of which the majority of each class of Voting Stock or other voting equity
and the majority of each other class of Capital Stock is owned by either (a) such Person or (b) another Subsidiary of such Person. 

        "Voting Stock" shall mean, with respect to any Person, the Capital Stock of any class or kind ordinarily having the power to vote for the
election of directors, managers, Stockholder Representatives or other members of the governing body of such Person. 

2.     Recapitalization.  

        2.1    Authorization of Shares.    On or prior to the Closing (as defined below), the Company shall have authorized
the issuance of the Series A Preferred Stock and the Series B Preferred Stock in the amounts and to the Stockholders identified on  Exhibit A attached hereto (the "Recapitalization Allocation"). The Series A Preferred
Stock and the Series B Preferred Stock shall have the rights, preferences, privileges and restrictions set forth in the Restated Certificate of Incorporation of the Company attached hereto as  Exhibit B (the "Restated Certificate of Incorporation"). 

        2.2    Recapitalization.    Subject to the terms and conditions set forth in this Agreement, effective at the Closing,
(i) the Carlyle Entities will transfer and convey to the Company the 5,500,000 shares of Class A Common Stock held by the Carlyle Entities, and (ii) Conexant will transfer and
convey to the Company the 4,500,000 shares of Class B Common Stock held by Conexant. In consideration of the transfer and conveyance of shares of Class A Common Stock and Class B
Common Stock referred to in the immediately preceding sentence, at the Closing (i) the Company shall issue and deliver to each Carlyle Entity and each Carlyle Entity shall accept and receive
from the Company, the whole number of fully paid and non-assessable shares of Series A Preferred Stock set forth opposite such Carlyle Entity's name in Exhibit A hereto, and
(ii) the Company shall issue and deliver to Conexant and Conexant shall accept and receive from the Company, the whole number of fully paid and non-assessable shares of
Series B Preferred Stock set forth opposite Conexant's name in Exhibit A hereto. 

        2.3    Tax Free Reorganization.    The Recapitalization of the outstanding shares of Common Stock for the shares of
Designated Preferred Stock is intended to qualify as a "recapitalization" within the meaning of Section 368(a)(1)(E) of the Internal Revenue Code of 1986, as amended (the
"Code"), and this Agreement is intended to constitute a "plan of reorganization" within the meaning of Sections 1.368-2(g) and
1.368-3 of the United States Income Tax Regulations. No
party hereto shall take any action which is inconsistent with such intent and each party hereto shall cause all tax returns relating to the Recapitalization to be filed on the basis of treating the
Recapitalization as a "recapitalization" within the meaning of Section 368(a)(1)(E) of the Code. 

3.     Closing and Delivery.  

        3.1    Closing.    The closing of the Recapitalization (the "Closing")
shall take place on the second business day after the satisfaction or waiver of the conditions set forth in Sections 6.1 and 6.2, at the offices of Latham & Watkins, 555 Eleventh Street, NW,
Suite 1000, Washington, D.C. 20004 (such date is hereinafter referred to as the "Closing Date"). 

2

 

        3.2    Delivery.    Subject to the terms and conditions hereof, the Company will deliver the shares of Designated
Preferred Stock at the Closing, in each case in the amounts and to the Stockholders as set forth on Exhibit A hereto, by delivery of a certificate or certificates evidencing the shares of
Designated Preferred Stock to be issued at the Closing, free and clear of all liens, claims, and encumbrances (collectively, an "Encumbrance"), and each
Stockholder will deliver the shares of Common Stock required to be delivered by such Stockholder at the Closing, in each case in the amounts and by the Stockholders as set forth on Exhibit A
hereto, by delivery of the certificate or certificates representing the shares of Common Stock to be exchanged for the shares of Designated Preferred Stock at the Closing, free and clear of all
Encumbrances. 

4.     Representations and Warranties of the Stockholders.  

        Each Stockholder hereby, severally and not jointly, represents and warrants to the Company as follows: 

        4.1    Requisite Power; Authorization; Binding Obligations.    Such Stockholder has all requisite power and authority
to execute and deliver this Agreement and the Related Agreements (as defined in Section 6.1(c) below) and to carry out the provisions of this Agreement and the Related Agreements. All action on
such Stockholder's part necessary for the authorization, execution and delivery of this Agreement and the Related Agreements, the consummation of the transactions contemplated hereby and thereby, and
the performance of all obligations of such Stockholder hereunder and thereunder has been or will be taken prior to the Closing. This Agreement and the Related Agreements, when executed and delivered,
will be valid and binding obligations of such Stockholder enforceable against it in accordance with their terms, except as limited by (a) applicable bankruptcy, insolvency,
reorganization, moratorium or other laws of general application affecting enforcement of creditors' rights, and (b) general principles of equity that restrict the availability of equitable
remedies. 

        4.2    Investment Representations.    Such Stockholder understands that neither the shares of the Common Stock nor the
shares of the Designated Preferred Stock have been registered under the Securities Act of 1933, as amended (the "Securities Act"). Such Stockholder also understands that the shares of Designated
Preferred Stock are being offered pursuant to an exemption from registration contained in the Securities Act based in part upon such Stockholder's following representations and warranties: 

        (a)    Stockholder Bears Economic Risk.    Such Stockholder has substantial experience in
evaluating and investing in private placement transactions of securities in companies similar to the Company so that it is capable of evaluating the merits and risks of its investment in the Company
and has the capacity to protect its own interests. Such Stockholder understands that it must bear the economic risk of this investment indefinitely unless the shares of Designated Preferred Stock are
registered pursuant to the Securities Act, or an exemption from registration is available. Such Stockholder understands that the Company has no present intention of registering the shares of
Designated Preferred Stock or any shares of its Common Stock. Such Stockholder also understands that there is no assurance that any exemption from registration under the Securities Act will be
available and that, even if available, such exemption may not allow such Stockholder to transfer all or any portion of the shares of Designated Preferred Stock under the circumstances, in the amounts
or at the times such Stockholder might propose. 

        (b)    Acquisition for Own Account.    Such Stockholder is acquiring the shares of Designated
Preferred Stock for its own account for investment only, and not with a view towards their distribution. 

        (c)    Each Stockholder Can Protect Its Interest.    Such Stockholder represents that by
reason of its, or of its management's, business or financial experience, such Stockholder has the capacity to protect its own interests in connection with the transactions contemplated in this
Agreement 

3

 

and
the Related Agreements. Further, such Stockholder is aware of no publication of any advertisement in connection with the transactions contemplated in this Agreement. 

        (d)    Accredited or Regulation S Eligible Investor.    Such Stockholder is an
"accredited investor" within the meaning of Regulation D under the Securities Act, or is not a "U.S. Person" within the meaning of Regulation S under the Securities Act. 

        (e)    Company Information.    Such Stockholder has had an opportunity to discuss the
Company's business, management and financial affairs with directors, officers and management of the Company and has had the opportunity to review the Company's operations and facilities. Such
Stockholder has also had the
opportunity to ask questions of and receive answers from the Company and its management regarding the terms and conditions of this investment. 

        4.3    Transfer Restrictions.    Such Stockholder acknowledges and agrees that the shares of Designated Preferred
Stock shall be subject to restrictions on transfer as set forth in the Amended and Restated Stockholder Agreement attached hereto as Exhibit C
(the "Amended and Restated Stockholder Agreement"). 

        4.4    Ownership of Shares of Common Stock.    Such Stockholder represents that the shares of Common Stock held by
such Stockholder as set forth on Exhibit A hereto are owned of record and beneficially by such Stockholder, free and clear of any Encumbrances, and such Stockholder has the full and
unrestricted right, power and authority to transfer such shares of Common Stock to the Company. 

5.     Representations and Warranties of the Company.  

        The Company hereby represents and warrants to each Stockholder as of the date of this Agreement and the Closing Date as follows: 

        5.1    Requisite Power; Authorization; Binding Obligations.    The Company has all requisite power and authority to
execute and deliver this Agreement and the Related Agreements and to carry out the provisions of this Agreement and the Related Agreements. All corporate action on the part of the Company, its
officers, directors and shareholders necessary for the authorization, execution and delivery of this Agreement and the Related Agreements, the consummation of the transactions contemplated hereby and
thereby, and the performance of all obligations of the Company hereunder and thereunder has been or will be taken prior to the Closing. This Agreement and the Related Agreements, when executed and
delivered, will be valid and binding obligations of the Company enforceable against it in accordance with their terms, except as limited by (a) applicable bankruptcy, insolvency,
reorganization, moratorium or other laws of general application affecting enforcement of creditors' rights, and (b) general principles of equity that restrict the availability of equitable
remedies. 

        5.2    Valid Issuance.    When issued at the Closing in accordance with the provisions of this Agreement and the
Restated Certificate of Incorporation, the shares of Designated Preferred Stock will be duly authorized, validly issued, fully paid and non-assessable, will be delivered free and clear of
any Encumbrances, and will have the rights, preferences, privileges and restrictions set forth in the Restated Certificate of Incorporation; provided, however, that such shares of Designated Preferred
Stock shall be subject to restrictions on transfer as set forth in the Amended and Restated Stockholder Agreement and may be subject to restrictions on transfer under state or federal securities laws
or as otherwise required by such laws at the time a transfer is proposed. 

6.     Conditions to Closing.  

        6.1    Conditions to Obligation of Each Stockholder.    Each Stockholder's obligation to accept the issuance of the
shares of Designated Preferred Stock and to deliver such Stockholder's shares of 

4

 

Common
Stock at the Closing is subject to the satisfaction, at or prior to the Closing Date, of the following conditions: 

        (a)    Performance of Obligations.    The Company shall have performed all obligations and
conditions herein required to be performed or observed by it on or prior to the Closing Date. 

        (b)    Representations and Warranties True.    The representations and warranties made by the
Company in Section 5 hereof shall be true and correct in all material respects as of the Closing Date with the same force and effect as if they had been made on and as of the Closing Date. 

        (c)    Related Agreements.    The Company and the other Stockholders shall have executed and
delivered to such Stockholder the Amended and Restated Stockholder Agreement, the Amended and Restated Registration Rights Agreement attached hereto as  Exhibit D (the "Amended and Restated Registration Rights Agreement"), the Amended and Restated
Carlyle Board Representation Agreement attached hereto as Exhibit E (the "Amended and Restated Carlyle Board
Representation Agreement"), and the Amended and Restated Conexant Board Representation Agreement attached hereto as  Exhibit F (the "Amended and
Restated Conexant Board Representation Agreement" and, together with
the Amended and Restated Stockholder Agreement, the Amended and Restated Registration Rights Agreement, and the Amended and Restated Carlyle Board Representation Agreement, the
"Related Agreements"). 

        6.2    Conditions to Obligations of the Company.    The Company's obligation to issue and deliver the shares of
Designated Preferred Stock for the shares of Common Stock at the Closing is subject to the satisfaction, at or prior to the Closing Date, of the following conditions: 

        (a)    Performance of Obligations.    Each Stockholder shall have performed all obligations
and conditions herein required to be performed or complied with by it on or prior to the Closing Date. 

        (b)    Representations and Warranties True.    The representations and warranties made by each
Stockholder in Section 4 hereof shall be true and correct in all material respects as of the Closing Date with the same force and effect as if they had been made on and as of the Closing Date. 

        (c)    Related Agreements.    Such Stockholder shall have executed and delivered to the
Company the Amended and Restated Stockholder Agreement, the Amended and Restated Registration Rights Agreement, the Amended and Restated Carlyle Board Representation Agreement, and the Amended and
Restated Conexant Board Representation Agreement. 

7.     Miscellaneous.  

        7.1    Governing Law.    This Agreement shall be construed in accordance with, and governed in all respects by, the
internal laws of the State of Delaware (without giving effect to principles of conflicts of laws). 

        7.2    Survival.    The representations, warranties, covenants and agreements made herein shall survive any
investigation made by any Stockholder and the closing of the transactions contemplated hereby. All statements as to factual matters contained in any certificate or other instrument delivered by or on
behalf of the Company pursuant hereto in connection with the transactions contemplated hereby shall be deemed to be representations and warranties by the Company hereunder solely as of the date of
such certificate or instrument. 

        7.3    Successors and Assigns; Assignment.    Each and all of the covenants, terms, provisions, and agreements
contained in this Agreement shall be binding upon and inure to the benefit of the parties hereto and, to the extent permitted by this Agreement, their respective successors and assigns. Neither the
Company nor any Stockholder may assign their respective rights or obligations under this Agreement (by operation of law or otherwise) to any Person (other than an Affiliate) without the prior 

5

 

written
consent of the Company, Conexant, and Carlyle, except in connection with a sale of all or substantially all of such first party's business. 

        7.4    Entire Agreement.    This Agreement and the exhibits hereto, the Related Agreements, and the other documents
delivered pursuant hereto constitute the full and entire understanding and agreement between the parties with regard to the subjects hereof, and no party shall be liable or bound to any other in any
manner by any representations, warranties, covenants and agreements except as specifically set forth herein and therein. 

        7.5    Severability.    In the event that any provision of this Agreement, or the application of any such provision to
any Person or set of circumstances, shall be determined to be invalid, unlawful, void or unenforceable to any extent, the remainder of this Agreement, and the application of such provision to entities
or circumstances other than those as to which it is determined to be invalid, unlawful, void or unenforceable, shall not be impaired or otherwise affected and shall continue to be valid and
enforceable to the fullest extent permitted by law. 

        7.6    Amendment.    This Agreement may not be amended, modified, altered or supplemented without the written consent
of the Company and each Stockholder. 

        7.7    Waiver.    

        (a)   No
failure on the part of any Person to exercise any power, right, privilege or remedy under this Agreement, and no delay on the part of any Person in exercising any
power, right, privilege or remedy under this Agreement, shall operate as a waiver of such power, right, privilege or remedy; and no single or partial exercise of any such power, right, privilege or
remedy shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy. 

        (b)   No
Person shall be deemed to have waived any claim arising out of this Agreement, or any power, right, privilege or remedy under this Agreement, unless the waiver of
such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such Person; and any such waiver shall not be applicable or have
any effect except in the specific instance in which it is given. 

        7.8    Notices.    All notices required or permitted hereunder shall be in writing and shall be deemed effectively
given: (a) upon personal delivery to the party to be notified; (b) when sent by confirmed telex or facsimile if sent during normal business hours of the recipient, if not, then on the
next business day; (c) five days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (d) one business day after deposit with a
nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the addresses set forth below: 

        If
to the Company or Carlyle: 

The
Carlyle Group

101 S. Tryon Street, 25th Floor

Charlotte, N.C., 28280

Attn: Claudius E. Watts, IV

Facsimile: (704) 632-0299 

        with
a copy to: 

Latham &
Watkins

555 11th Street, NW, Ste. 1000

Washington, D.C., 20004-1204

Attn: Raymond B. Grochowski, Esq.

Facsimile: (202) 637-2201 

6

 

        If
to Conexant: 

Conexant
Systems, Inc.

4311 Jamboree Road

Newport Beach, CA 92660

Attn: General Counsel

Facsimile: (949) 483-9576 

        with
a copy to: 

Cooley
Godward LLP

4401 Eastgate Mall

San Diego, CA 92121

Attn: Carl R. Sanchez, Esq.

Facsimile: (858) 550-6420 

        7.9    Remedies Cumulative; Specific Performance.    The rights and remedies of the parties hereto shall be cumulative
(and not alternative). The parties hereto agree that: (a) in the event of any breach or threatened breach by any party of any covenant, obligation or other provision set forth in this
Agreement, the other parties shall be entitled (in addition to any other remedy that may be available to it) to (i) a decree or order of specific performance or mandamus to enforce the
observance and performance of such covenant, obligation or other provision, and (ii) an injunction restraining such
breach or threatened breach; and (b) such other parties shall not be required to provide any bond or other security in connection with any such decree, order or injunction or in connection with
any related action or Proceeding. 

        7.10    Further Assurances.    

        Each
party hereto shall execute and/or cause to be delivered to each other party hereto such instruments and other documents, and shall take such other actions, as such other party may
reasonably request (prior to, at or after the Closing) for the purpose of carrying out or evidencing any of the transactions contemplated hereby. 

        7.11    Termination.    This Agreement may be terminated upon the mutual written consent of the Company, Carlyle and
Conexant. 

        7.12    Construction; Interpretation.    For purposes of this Agreement, whenever the context requires: the singular
number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter
gender shall include the masculine and feminine genders. 

        (b)   The
parties hereto agree that any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be applied in the
construction or interpretation of this Agreement. 

        (c)   All
monetary amounts referenced herein are denominated in United States Dollars. 

        (d)   As
used in this Agreement, the words "include" and "including," and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be
followed by the words "without limitation." 

        (e)   Except
as otherwise indicated, all references in this Agreement to "Sections" and
"Exhibits" are intended to refer to Sections of this Agreement and Exhibits to this Agreement. 

        7.13    Counterparts.    This Agreement may be executed in any number of counterparts, each of which shall be an
original, but all of which together shall constitute one instrument. 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK] 

7

        IN WITNESS WHEREOF, the parties hereto have executed this RECAPITALIZATION AGREEMENT as of
the date set forth in the first paragraph hereof. 

	 	 	JAZZ SEMICONDUCTOR, INC.,

a Delaware corporation
	

 	
 	

By:	
 	

/s/  SHU LI      

	 	 	Name:	 	Shu Li
	 	 	Title:	 	President and Chief Executive Officer
	

 	
 	
CONEXANT SYSTEMS, INC.,

a Delaware corporation
	 	 	By:	 	/s/  DWIGHT DECKER      

	 	 	Name:	 	Dwight Decker
	 	 	Title:	 	Chief Executive Officer
	

 	
 	
CARLYLE PARTNERS III, L.P.,

a Delaware limited partnership
	

 	
 	

By:	
 	

TC Group III, L.P.,

its General Partner
	

 	
 	

By:	
 	

TC Group III, L.L.C.,

its General Partner
	

 	
 	

By:	
 	

TC Group, L.L.C.,

its Managing Member
	

 	
 	

By:	
 	

TCG Holdings, L.L.C.,

its Managing Member
	

 	
 	

By:	
 	

/s/  ALLAN M. HOLT      

	 	 	Name:	 	Allan M. Holt
	 	 	Title:	 	Managing Director

	

 	
 	
CP III COINVESTMENT, L.P.,

a Delaware limited partnership
	

 	
 	

By:	
 	

TC Group III, L.P.,

its General Partner
	

 	
 	

By:	
 	

TC Group III, L.L.C.,

its General Partner
	

 	
 	

By:	
 	

TC Group, L.L.C.,

its Managing Member
	

 	
 	

By:	
 	

TCG Holdings, L.L.C.,

its Managing Member
	

 	
 	

By:	
 	

/s/  ALLAN M. HOLT      

	 	 	Name:	 	Allan M. Holt
	 	 	Title:	 	Managing Director
	

 	
 	
CARLYLE HIGH YIELD PARTNERS, L.P.,

a Delaware limited partnership
	

 	
 	

By:	
 	

TCG High Yield, L.L.C.,

its General Partner
	

 	
 	

By:	
 	

TCG High Yield Holdings, L.L.C.,

its Managing Member
	

 	
 	

By:	
 	

TC Group, L.L.C.,

its sole Member
	

 	
 	

By:	
 	

TCG Holdings, L.L.C.,

its Managing Member
	

 	
 	

By:	
 	

/s/  ALLAN M. HOLT      

	 	 	Name:	 	Allan M. Holt
	 	 	Title:	 	Managing Director

EXHIBIT A  

RECAPITALIZATION ALLOCATION  

	STOCKHOLDER
 
	 	SHARES OF COMMON

STOCK TO BE

EXCHANGED
	 	SHARES OF

DESIGNATED

PREFERRED STOCK TO

BE ISSUED

	Carlyle Partners III, L.P.

c/o The Carlyle Group

1001 Pennsylvania Avenue, NW

Washington, D.C. 20004	 	5,025,444 shares of Class A Common Stock	 	50,254,440 shares of Series A Preferred Stock
	CP III Coinvestment, L.P.

c/o The Carlyle Group

1001 Pennsylvania Avenue, NW

Washington, D.C. 20004	 	199,556 shares of Class A Common Stock	 	1,995,560 shares of Series A Preferred Stock
	Carlyle High Yield Partners, L.P.

c/o The Carlyle Group

1001 Pennsylvania Avenue, NW

Washington, D.C. 20004	 	275,000 shares of Class A Common Stock	 	2,750,000 shares of Series A Preferred Stock
	Conexant Systems, Inc.

4311 Jamboree Road

Newport Beach, CA 92660	 	4,500,000 shares of Class B Common Stock	 	45,000,000 shares of Series B Preferred Stock
	TOTAL	 	10,000,000 shares of Common Stock	 	100,000,000 shares of Designated Preferred Stock

EXHIBIT B  

RESTATED

CERTIFICATE OF INCORPORATION

OF

JAZZ SEMICONDUCTOR, INC.  

(SEE TAB 6)  

 EXHIBIT C  

AMENDED AND RESTATED

STOCKHOLDER AGREEMENT  

(SEE TAB 2)  

 EXHIBIT D  

AMENDED AND RESTATED

REGISTRATION RIGHTS AGREEMENT  

(SEE TAB 3)  

 EXHIBIT E  

AMENDED AND RESTATED

CARLYLE BOARD REPRESENTATION AGREEMENT  

(SEE TAB 4)  

 EXHIBIT F  

AMENDED AND RESTATED

CONEXANT BOARD REPRESENTATION AGREEMENT  

(SEE TAB 5)  

QuickLinks

RECAPITALIZATION AGREEMENTQuickLinks
 -- Click here to rapidly navigate through this document

Exhibit 10.34  

 
 

AMENDED AND RESTATED PREFERRED STOCK PURCHASE AGREEMENT    
    

        THIS AMENDED AND RESTATED PREFERRED STOCK PURCHASE AGREEMENT (the "Agreement") is made on the 15th
day of October, 2002 (the "Effective Date"), by and between JAZZ SEMICONDUCTOR, INC., a Delaware corporation (the
"Company"), and RF MICRO DEVICES, INC., a North Carolina corporation
("RFMD"), and amends and fully restates in its entirety as set forth herein that certain Preferred Stock Purchase Agreement dated as of
August 22, 2002, by and between the Company and RFMD (the "Original Purchase Agreement"). 

        1.    Subscription for and Issuance of Preferred Stock.    

        1.1.    Authorization and Sale of Series B Preferred Stock.    

        (a)   The
Company has authorized the issuance to RFMD of up to an aggregate of Thirteen Million Seventy One Thousand Eight Hundred Eighty Eight (13,071,888) shares of
Series B Preferred Stock (the "Shares"). The rights, restrictions, privileges and preferences of the Series B Preferred Stock shall be set
forth in the Company's Certificate of Incorporation in the form attached hereto as Exhibit A (the
"Certificate"), the parties hereto acknowledging and agreeing that Exhibit A attached hereto
differs in certain respects from Exhibit A attached to the Original Purchase Agreement. At or before the Closing (as defined below), the Company shall adopt the Certificate and file the same
with the Secretary of State of the State of Delaware. The total amount of common stock, par value $0.001 per share of the Company (the "Common Stock"),
or other securities issuable upon conversion of the Shares is referred to as the "Conversion Stock." 

        (b)   Subject
to the terms and conditions of this Agreement, RFMD agrees to purchase the Shares for an aggregate purchase price of Sixty Million dollars ($60,000,000) (the
"Purchase Price"). The Purchase Price shall be comprised of (1) cash in the amount of Thirty Million dollars ($30,000,000) (the
"Cash Portion") and (2) a Promissory Note in the principal amount of Thirty Million dollars ($30,000,000) in substantially the form attached
hereto as Exhibit B (the "Note"). Payment of the Note shall be secured under a pledge agreement
in substantially the form attached hereto as Exhibit C (the "Pledge Agreement"). As used in this
Agreement, the term "Transaction Documents" shall mean the Note, the
Pledge Agreement, the Stockholder Agreement, the Board Representation Agreements, the Registration Rights Agreement, the Wafer Supply Agreement and the Development Agreement, each as defined herein. 

        1.2.    Closing.    

        (a)   The
Closing of the issuance of the Shares shall take place on the second business day following the date upon which each of the conditions to closing have been satisfied
at the offices of Latham & Watkins, 650 Town Center Drive, Costa Mesa, California 92626 (the "Closing") or at such other time and place as the
Company and RFMD mutually agree upon orally or in writing. The date on which the Closing occurs is referred to herein as the "Closing Date." 

        (b)   At
the Closing, RFMD shall pay the Cash Portion in immediately available funds by check or wire transfer to a bank account designated by the Company and shall deliver
the following to the Company: 

        (i)    the
Note, duly executed by RFMD; 

        (ii)   the
Pledge Agreement, duly executed by RFMD; 

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

 

        (iii)    a
Second Amended and Restated Stockholder Agreement substantially in the form attached hereto as  Exhibit D (the "Stockholder Agreement"), duly
executed by RFMD, the parties hereto acknowledging
and agreeing that Exhibit D attached hereto differs in certain respects from Exhibit D attached to the Original Purchase Agreement; 

        (iv)  a
Second Amended and Restated Carlyle Board Representation Agreement substantially in the form attached hereto as  Exhibit E (the "Carlyle Board Representation
Agreement"), duly executed by RFMD; 

        (v)   a
Second Amended and Restated Conexant Board Representation Agreement substantially in the form attached hereto as  Exhibit F (the "Conexant Board Representation
Agreement"), duly executed by RFMD; 

        (vi)  a
RFMD Board Representation Agreement substantially in the form attached hereto as Exhibit G (the
"RFMD Board Representation Agreement" and, together with the Carlyle Board Representation Agreement and the Conexant Board Representation Agreement, the
"Board Representation Agreements"), duly executed by RFMD; 

        (vii)   a
Registration Rights Agreement substantially in the form attached hereto as Exhibit H (the
"Registration Rights Agreement"), duly executed by RFMD; 

        (viii)   a
Wafer Supply Agreement substantially in the form attached hereto as Exhibit I (the
"Wafer Supply Agreement"), duly executed by RFMD, the parties hereto acknowledging and agreeing that  Exhibit I attached hereto differs in
certain respects from Exhibit I attached to the Original Purchase Agreement; 

        (ix)  a
Master Joint Technology Development Agreement substantially in the form attached hereto as Exhibit J (the
"Development Agreement"), duly executed by RFMD; and 

        (x)   a
certificate or certificates, duly executed by the Chief Executive Officer or Chief Financial Officer of RFMD and dated as of the Closing Date, certifying the
fulfillment of the conditions specified in Sections 5.2(a), (b),  (c) and (f) hereof (the "RFMD Compliance
Certificate"). 

        (c)   At
the Closing, the Company shall deliver to RFMD: 

        (i)    the
Pledge Agreement, duly executed by the Company; 

        (ii)   the
Stockholder Agreement, duly executed by each of Carlyle Partners III, L.P., a Delaware limited partnership ("CP
III"), CP III Coinvestment, L.P., a Delaware limited partnership ("CP III Coinvestment"), Carlyle High Yield Partners, L.P., a
Delaware limited partnership ("Carlyle High Yield" and, together with CP III and CP III Coinvestment,
"Carlyle"), Conexant Systems, Inc., a Delaware corporation ("Conexant" and, together with
Carlyle, the "Existing Stockholders") and the Company; 

        (iii)    the
Board Representation Agreements, duly executed by all parties thereto other than RFMD; 

        (iv)  the
Registration Rights Agreement, duly executed by Conexant, Carlyle and the Company; 

        (v)   an
opinion letter from the Company's counsel, Latham & Watkins, addressed to RFMD and substantially in the form attached hereto as  Exhibit K (the "Opinion"), the parties hereto acknowledging and agreeing that  Exhibit K attached hereto differs in certain respects from Exhibit K attached to the
Original Purchase Agreement; 

        (vi)  the
Wafer Supply Agreement, duly executed by Newport Fab, LLC, a Delaware limited liability company ("Newport Fab"); 

2

 

        (vii)   the
Development Agreement, duly executed by Newport Fab; 

        (viii)   evidence
of the election of RFMD's designee to the Board of Directors of the Company pursuant to the RFMD Board Representation Agreement; 

        (ix)  an
indemnification agreement duly executed by the Company in favor of RFMD's designee on the Board of Directors of the Company in accordance with  Section 4.5 of this Agreement; 

        (x)   a
certificate or certificates, duly executed by the Chief Executive Officer or Chief Financial Officer of the Company and dated as of the Closing Date, certifying the
fulfillment of the conditions specified in Sections 5.1(a),  (b) (c), (d)
 and  (g) (the "Company Compliance Certificate"); 

        (xi)  a
true and correct copy of a certificate or certificates evidencing the Shares, which original certificates shall be dated as of the Closing Date and delivered to the
Company to hold as Pledged Collateral under the Pledge Agreement. 

        2.    Representations and Warranties of the Company.    As a material inducement to RFMD to enter into this Agreement
and purchase the Shares hereunder, the Company hereby represents and warrants to RFMD that: 

        2.1.    Organization and Standing.    The Company is a corporation duly organized, validly existing under, and in good
standing under, the laws of the State of Delaware. The Company has all requisite corporate power and authority to own and operate its properties and assets and to carry on its business as presently
conducted. The Company is duly qualified and authorized to do business and is in good standing as a foreign corporation in the State of California and in each jurisdiction in which the failure to be
so qualified would have a material adverse effect on the Company's business as presently conducted or its assets, liabilities, results of operation or financial condition, taken as a whole (a
"Material Adverse Effect"). 

        2.2.    Corporate Power.    The Company has full power and authority to enter into this Agreement and the other
Transaction Documents and to carry out the provisions of this Agreement and the other Transaction Documents, and such agreements constitute the Company's valid and legally binding obligation,
enforceable in accordance with their terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of
creditors' rights generally and (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies. The Certificate and the Company's
Bylaws, attached hereto as Exhibit L (the "Bylaws"), are, as of August 22, 2002, true and
complete copies of the Company's Certificate of Incorporation and Bylaws, including all amendments to each. 

        2.3.    Authorization.    All corporate action on the part of the Company, its officers, directors and stockholders
necessary for the authorization, execution, delivery and performance by the Company of this Agreement and the other Transaction Documents, the due authorization, issuance (or reservation for
issuance), sale and delivery of the Shares and the Conversion Stock, and the performance of all of the Company's obligations hereunder and thereunder has been taken (with respect to this Agreement) or
will be taken (with respect to the other Transaction Documents) prior to the Closing. The Conversion Stock will have been duly and validly reserved for issuance prior to the Closing. The Shares, when
issued, sold and delivered in compliance with the provisions of this Agreement, and the Conversion Stock, when issued in compliance with the provisions of the Certificate, will be duly authorized,
validly issued, fully paid and nonassessable and issued in compliance with applicable federal securities laws, the Shares will have the rights, preferences and privileges described in the Certificate,
and the Shares and the Conversion Stock will be free and clear of all liens, claims and encumbrances and any "adverse claim" (as such term is defined in 

3

 

Section 8102
of the California Commercial Code), assuming RFMD takes the Shares and the Conversion Stock with no notice thereof, other than any liens or encumbrances created by or imposed upon
RFMD and encumbrances imposed by any law, rule, regulation, ordinance or restriction promulgated by any governmental authority; provided, however, that the Shares and the Conversion Stock may be
subject to restrictions on transfer under applicable securities laws and otherwise as set forth herein and in the Stockholder Agreement and the lien and encumbrances created by the Pledge Agreement. 

        2.4.    No Conflict or Breach.    The execution, delivery and performance by the Company of this Agreement and the
Transaction Documents do not and will not (a) assuming compliance with the requirements of the HSR Act (as defined herein), conflict with or constitute a violation of any law, statute, judgment
or regulation of any legislative body, court, administrative agency, governmental authority or arbitrator applicable to the Company; (b) conflict with or constitute a violation of the
Certificate of Incorporation or Bylaws of the Company; or (c) constitute or cause a breach or violation of any covenant, agreement or obligation binding upon the Company or affecting any of its
properties, except, in the case of such conflicts, violations or breaches described in the foregoing (a) or (c), such as would not have a Material Adverse Effect. 

        2.5.    Capitalization    

        (a)   As
of the Closing, the authorized capital stock of the Company will consist of 225,000,000 shares of Common Stock and 200,000,000 shares of Preferred Stock, $0.001 par
value, of which 55,000,000 shares shall have been designated Series A Preferred Stock and 58,071,888 shares shall have been designated Series B Preferred Stock. Immediately prior to the
Closing, no shares of Common Stock, 55,000,000 shares of Series A Preferred Stock and 45,000,000 shares of Series B Preferred Stock will be issued and outstanding.  Schedule 2.5(a) contains a table setting forth (i) a list of all holders of Preferred Stock as of August 22, 2002, including the
number of shares of Preferred Stock held by each such holder, (ii) the total number of shares of Common Stock outstanding as of August 22, 2002 and (iii) the total number of
options to purchase shares of capital stock or other securities of the Company outstanding as of August 22, 2002. All issued and outstanding shares of the Company's capital stock have been duly
authorized and validly issued, are fully paid and nonassessable, and were issued in compliance with
applicable federal securities laws. As of August 22, 2002, except as stated in this Section 2.5(a) above or in  Schedule 2.5(a) and except
for (i) the conversion privileges of the Preferred Stock (ii) 17,647,000 shares of Common Stock reserved
for issuance under the Company's 2002 Equity Incentive Plan and (iii) the preemptive rights provided in the Amended and Restated Stockholder Agreement dated as of July 30, 2002, by and
among the Existing Stockholders, there are no other outstanding shares of capital stock, stock appreciation rights, phantom stock or similar rights, or outstanding rights of first refusal or rights to
purchase or otherwise acquire from the Company any securities of the Company, preemptive rights or other rights, options, warrants, conversion rights, or other agreements or understandings either
directly or indirectly for the purchase or acquisition from the Company of any shares of its capital stock. With the exception of the Stockholder Agreement and the Board Representation Agreements, the
Company is not, and as of immediately after the Closing will not be, a party or otherwise subject to any agreement or understanding that affects or relates to the voting or giving of written consents
with respect to any security of the Company, or the voting by or for a director of the Company, including without limitation voting trusts or agreements, stockholders' agreements, pledge agreements,
buy-sell agreements, rights of first refusal or proxies relating to capital stock of the Company. 

        (b)   As
of the Closing, the Company will not be subject to any obligation (contingent or otherwise) to repurchase or otherwise acquire or retire any of its securities or any
options, warrants or other rights to acquire any of its securities. 

4

 

        (c)   As
of the Effective Date, the Company does not own or control, either directly or indirectly, more than 50% of the ownership or voting interests of any entity, except
for those entities set forth on Schedule 2.5(c). The Company's ownership in each of the entities set forth on  Schedule 2.5(c) is free from liens,
claims and encumbrances other than any liens or encumbrances created by or imposed by any law, rule,
regulation, ordinance or restriction promulgated by any governmental authority or restrictions on transfer under applicable securities laws. 

        2.6.    Outstanding Indebtedness.    Except as set forth in the Financial Statements (as such term is defined below)
or identified on Schedule 2.5(c), the Company has no indebtedness for borrowed money which the Company has directly or indirectly created,
incurred, assumed or guaranteed, or with respect to which the Company has become directly or indirectly liable. 

        2.7.    Financial Statements.    The Company has delivered to RFMD its unaudited balance sheet as of June 28,
2002 (the "Statement Date") and unaudited statement of income and cash flows for the fiscal months ended April 26, 2002, May 24, 2002, and
the fiscal three months ended June 28, 2002, (collectively, the "Financial Statements"). Except as set forth in  Schedule 2.7, each of the
Financial Statements, is complete and correct in all material respects, has been prepared in accordance with generally
accepted accounting principles applied on a basis consistent throughout the periods indicated and consistent with the other Financial Statements, except as disclosed therein, and presents fairly, in
all material respects, the financial position and operating results of the Company as of the Statement Date or for the periods indicated therein; provided, however, that the Financial Statements are
subject
to year-end audit adjustments as well as opening balance sheet purchase accounting adjustments and do not contain footnotes required under generally accepted accounting principles. 

        2.8.    Governmental Consents.    No consent, approval, order or authorization of, or registration, qualification,
designation, declaration or filing with, any governmental authority on the part of the Company is required in connection with the consummation of the transactions contemplated by this Agreement,
except for such filings, if any, required pursuant to applicable securities laws, which filings will be duly effected within all required statutory periods, and except as may be required by the HSR
Act (as defined herein). 

        2.9.    Litigation.    Except for certain actions and proceedings described in  Schedule 2.9, there is no action, suit,
proceeding or investigation pending or to the best of the Company's knowledge, currently threatened
against the Company that questions the validity of this Agreement or the right of the Company to enter into this Agreement or to consummate the transactions contemplated hereby, or that might result,
either individually or in the aggregate, in any Material Adverse Effect. 

        2.10.    Changes.    Except in connection with the Transaction Documents, as contemplated in the Company's Operating
Budget as of or prior to the Effective Date (which Operating Budget has previously been delivered by the Company to RFMD), or as described in  Schedule 2.10, since the Statement Date: 

        (a)   no
Material Adverse Effect has occurred; 

        (b)   there
has been no damage, destruction or loss not covered by insurance that has resulted in a Material Adverse Effect; 

        (c)   no
other event or condition of any character has occurred that could be reasonably expected to have a Material Adverse Effect; 

        (d)   the
Company has not sold, leased, transferred, or assigned any of its assets, tangible or intangible, having a value greater than $10,000,000 in the aggregate; 

5

 

        (e)   the
Company has not entered into any agreement, contract, commitment, lease, or license (or series of related agreements, contracts, commitments, leases, and licenses)
involving more than $15,000,000 per year, other than in the ordinary course of business; 

        (f)    no
party (including the Company) has accelerated, terminated, modified, or cancelled any agreement, contract, lease, or license (or series of related agreements,
contracts, leases, and licenses) to which the Company is a party or by which the Company or its assets are bound which obligates any party thereto to provide goods and/or services having a value, or
to make payments aggregating, in excess of $5,000,000 per year; 

        (g)   the
Company has not made any capital investment in, any loan to, or any acquisition of the securities or assets of any other person (or series of related capital
investments, loans, and acquisitions) involving more than $5,000,000, other than in the ordinary course of business; 

        (h)   the
Company has not issued any note, bond, or other debt security or created, incurred, assumed, or guaranteed any indebtedness for borrowed money or capitalized lease
obligation (but, in any event, excluding indebtedness and accounts payable incurred in the ordinary course of business) involving more than $1,000,000 in the aggregate; 

        (i)    the
Company has not made any loan to, or entered into any other transaction with, any of its directors, officers and employees outside the ordinary course of business; 

        (j)    the
Company has not issued shares of capital stock or granted stock appreciation rights, phantom stock or similar rights, options, warrants, rights of first refusal,
preemptive rights, conversion rights or other rights, or entered into any arrangements or understandings either directly or indirectly for the purchase or acquisition from the Company of any shares of
its capital stock, except for options to purchase Company stock issued under the 2002 Equity Incentive Plan and common stock issued upon the exercise or conversion of securities convertible into the
Company's common stock that are set forth on Schedule 2.5(a); 

        (k)   the
Company has not committed to do any of the foregoing. 

        2.11.    Proprietary Assets.    To the Company's knowledge and except as set forth on  Schedule 2.11: 

        (a)   the
Company owns, or otherwise possesses sufficient rights to use, all of the patents, patent applications, trademarks, service marks, trademark and service mark
applications, trade names, copyright registrations, and licenses currently used by the Company or necessary for the conduct of the Company's business as currently conducted (the
"Proprietary Assets"); 

        (b)   the
business of the Company as currently conducted does not infringe or violate any of the patents, trademarks, service marks, trade names, copyrights,
mask-works, licenses, trade secrets, processes, data or know-how ("Intellectual Property Rights") of any other person, except
such as would not have a Material Adverse Effect, and the Company has not received any notices of infringement with respect to the Intellectual Property Rights or the businesses of the Company; and 

        (c)   no
person (including employees of the Company) is infringing, misappropriating or otherwise making any unauthorized use or disclosure of any Intellectual Property Rights
of the Company, except such as would not have a Material Adverse Effect. 

        2.12.    Compliance with Decrees and Laws.    There is not outstanding any material order, writ, injunction or decree
of any court, governmental agency or arbitration tribunal against or involving the Company or any of its assets (a "Governmental Order"), and the
Company has not received any written notice of any pending or threatened Governmental Order. The Company is currently, and 

6

 

has
been at all times, in material compliance with all material laws, statutes, rules, regulations, orders and licensing requirements ("Rules") of
federal, state, local and foreign agencies and authorities applicable to the business, properties and operations of the Company (including, without limitation, those relating to antitrust and trade
regulation, civil rights, labor and discrimination, safety and health). To the knowledge of the Company, there has been no allegation of any violation of any such Rules, and no investigation or review
by any federal, state or local body or agency is, to the knowledge of the Company, pending, threatened or planned with respect to the Company or any of its assets. 

        2.13.    Taxes.    No tax returns, reports or declarations of estimated tax ("Tax
Returns") have been required to be filed before the date hereof with any United States, state and local governmental agencies or foreign countries and political subdivisions
thereof. The Company has timely made all withholdings of tax required to be made under all applicable United States, state and local tax regulations, and such withholdings have either been paid or
will be paid to the respective governmental agencies or set aside in accounts for such purpose or accrued, reserved against and entered upon the books of the Company. Estimated income taxes which are
not yet due to be paid to the Internal Revenue Service or any state or local taxing authority have been accrued, reserved against and entered upon the books of the Company. The Company is not a party
to any pending action or proceeding, nor to the knowledge of the Company, is there threatened any action or proceeding, by any governmental authority for assessment or collection of Taxes, and the
Company has not been notified by any governmental authority that an audit or review of any tax matter is contemplated. 

        2.14.    Disclosure.    The representations and warranties of the Company set forth in this Agreement (a) do
not contain a misstatement of a material fact or (b) intentionally omit to state a material fact necessary to make the statements contained herein not misleading (except as for such omissions
as would not reasonably be expected to have a Material Adverse Effect). 

        2.15.    Status of Company.    Since March 12, 2002, except as described on  Schedule 2.15, the Company has conducted its
business as a separate and independent corporation and not as a subsidiary of or otherwise
controlled by Conexant. RFMD acknowledges that the Company, in the normal course of its separation from Conexant and through the Effective Date received and provided services to Conexant under various
agreements, including but not limited to, a Transition Services Agreement pursuant to which Conexant and the Company have agreed to the sharing and transitioning of certain support services related to
the wafer fabrication operations of the Company (the "Transition Agreement") and the other Transactional Agreements (as such term is defined in the
Stockholder Agreement). As of the Effective Date, the Company is not, under any contractual arrangement, understanding or otherwise, sharing with, furnishing to or being provided by Conexant, or any
affiliate of Conexant, with any material assets, facilities, properties, equipment, personnel, operations, systems, services, functions or resources except pursuant to the Transactional Agreements and
the agreements and arrangements listed on Schedule 2.15. Any material services previously provided by Conexant to the Company and not provided
pursuant to the Transactional Agreements or agreements or arrangements listed on Schedule 2.15 have been terminated. 

        3.    Representations and Warranties of RFMD.    As a material inducement to the Company to enter into this Agreement
and sell the Shares hereunder, RFMD hereby represents and warrants to the Company that: 

        3.1.    Organization and Standing.    RFMD is a corporation duly organized, validly existing under, and in good
standing under, the laws of the State of North Carolina. RFMD has all requisite corporate power and authority to own and operate its properties and assets and to carry on its business as presently
conducted. 

7

 

        3.2.    Corporate Power.    RFMD has full power and authority to enter into this Agreement and the other Transaction
Documents, and such agreements constitute RFMD's valid and legally binding obligations, enforceable in accordance with their terms, except (i) as limited by applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting enforcement of creditors' rights generally and (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies. 

        3.3.    Authorization.    All corporate action on the part of RFMD, its officers, directors and stockholders necessary
for the authorization, execution, delivery and performance by the Company of this Agreement and the other Transaction Documents, and the performance of all of RFMD's obligations hereunder and
thereunder, has been taken (with respect to this Agreement) or will be taken (with respect to the other Transaction Documents) prior to the Closing. 

        3.4.    Experience.    RFMD is capable of evaluating the merits and risks of its investment in the Company and has the
capacity to protect its own interests. RFMD is an "accredited investor," as such term is defined in Regulation D promulgated under the Securities Act of 1933, as amended (the
"Securities Act"). 

        3.5.    Investment.    RFMD is acquiring the Shares (and the Conversion Stock) for investment for its own account, not
as a nominee or agent, and not with the view to, or for resale in connection with, any distribution thereof. RFMD understands that the Shares and the Conversion Stock have not been, and, when issued,
will not be, registered under the Securities Act by reason of a specific exemption from the registration provisions of the Securities Act, the availability of which depends upon, among other things,
the bona fide nature of the investment intent and the accuracy of RFMD's representations as expressed herein. 

        3.6.    Rule 144.    RFMD acknowledges that the Shares and the Conversion Stock must be held indefinitely
unless subsequently registered under the Securities Act or unless an exemption from such registration is available. RFMD is aware of the provisions of Rule 144 promulgated under the Securities
Act which permit limited resale of shares purchased in a private placement subject to the satisfaction of certain conditions, including, among other things, the existence of a public market for the
Shares, the availability of certain current public information about the Company, the resale occurring not less than one year after a party has purchased and paid for the security to be sold, the sale
being effected through a "broker's transaction" or in transactions directly with a "market maker" and the number of Shares and shares of Conversion Stock being sold during any three-month period not
exceeding specified limitations. 

        3.7.    No Public Market.    RFMD understands that no public market now exists for any of the securities issued by the
Company and that the Company has made no assurances that a public market will ever exist for the Company's securities. 

        3.8.    Access to Data.    RFMD has had an opportunity to discuss the Company's business, management and financial
affairs with the Company's management and has also had an opportunity to ask questions of the Company's officers, which questions were answered to its satisfaction. 

        3.9.    Brokers or Finders.    RFMD has not engaged any brokers, finders, or agents and has not incurred, and will not
incur, directly or indirectly, any liability for brokerage or finder's fee or agents' commissions or any similar charges in connection with this Agreement or the transactions contemplated hereby. 

        4.    Covenants.    

        4.1    HSR Filing.    The Company and RFMD shall, as promptly as practicable following the execution of this
Agreement, in cooperation with each other, complete and file with the 

8

 

appropriate
authorities the premerger notification forms and any other documents required under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and
regulations thereunder (the "HSR Act"). It is agreed that the Company and RFMD shall each pay one half of all filing fees due from the parties in
connection with compliance with the HSR Act. 

        4.2    Access to Information.    The Company shall permit RFMD and its counsel, accountants and other representatives
reasonable access during normal business hours to the properties, assets, books, records, agreements and other documents of the Company reasonably determined by the Company as necessary for RFMD to
receive information comparable to the information that will be made available to RFMD following the Closing under the Stockholder Agreement. 

        4.3.    Conduct of Business.    

        (a)   Between
the Effective Date and the Closing Date, except to the extent necessary to give effect to the transactions contemplated by this Agreement or the Transaction
Documents, the Company: 

        (i)    shall
conduct its operations in the normal and customary manner in the ordinary course of business, except as would not have a Material Adverse Effect; 

        (ii)   shall
keep in full force and effect insurance on its assets; 

        (iii)    shall
maintain its relationships with its employees, suppliers and customers, except as would not have a Material Adverse Effect; 

        (iv)  shall
promptly advise RFMD of any Material Adverse Effect in the condition of the Company, whether financial or tax (including notification of audit or other tax
investigation, tax lien filing or proposed tax lien); 

        (v)   shall
promptly advise RFMD of the occurrence of any event or circumstance which adversely affects the consummation of the transactions contemplated by this Agreement or
which, if in existence on the Effective Date, would have been required to have been disclosed in a schedule to this Agreement or
would have caused a representation or warranty of the Company in this Agreement to have been inaccurate; 

        (vi)  shall
not amend the Certificate or the Company's Bylaws; and 

        (vii)   shall
not take any of the actions specified in Sections 2.10(d) through  (k). 

        (b)   Between
the Effective Date and the Closing Date, RFMD: 

        (i)    shall
promptly advise the Company of any material adverse change in the condition of RFMD, whether financial or tax (including notification of audit or other tax
investigation, tax lien filing or proposed tax lien); 

        (ii)   shall
promptly advise the Company of the occurrence of any event or circumstance which adversely affects the consummation of the transactions contemplated by this
Agreement or which, if in existence on the Effective Date, would have been required to have been disclosed in a schedule to this Agreement or would have caused a representation or warranty of RFMD in
this Agreement to have been inaccurate. 

        (c)   From
and after the Closing Date, the Company: 

        (i)    shall
conduct its business as a separate and independent company and not as a subsidiary or otherwise controlled by Conexant; provided that (A) the Company may
continue to obtain the benefits of and perform its obligations under the Transactional Agreements and the agreements and arrangements listed on  Schedule 2.15, and (B) nothing in this
Section 4.3(c)(i) shall prevent the
Company from engaging in a 

9

 

Related
Party Transaction (as defined below) or series of related Related Party Transactions in which the amount involved is less than $60,000; 

        (ii)   shall
not, directly or indirectly, enter into, or agree to enter into, any contract, subcontract, license, option, loan or other agreement, written or oral, or series
of any related agreements with any director, executive officer or holder of more than 1% of the outstanding capital stock of the Company (each, a "Related Party
Transaction") in which the amount involved equals or exceeds $100,000, without the affirmative approval of a majority of the disinterested members of the Company's Board of
Directors; 

        (iii)    shall
not, without the prior consent of a majority of the disinterested directors, (A) take action to amend, modify, supplement, terminate,
extend, waive any right of the Company under or waive compliance by any other party with any material provision of any Transactional Agreement or (B) enter into new agreements, in either case,
that may result in a breach of confidentiality under the Stockholder Agreement or may materially impair the Company's ability to perform its obligations under the RFMD Agreements (as such term is
defined in the Shareholder Agreement). 

        4.4.    Best Efforts.    Each of the Company and RFMD shall use best efforts to make or obtain all consents,
approvals, authorizations, registrations and filings with all federal, state or local judicial or governmental authorities or administrative agencies as are required in connection with the
consummation of the transactions contemplated by this Agreement. 

        4.5.    RFMD Designee.    The Company shall take such commercially reasonable steps as are necessary to effect,
immediately after the Closing, the election to the Board of Directors of the Company of Jerry Neal, or such other designee as RFMD shall designate in writing to serve as the RFMD representative
pursuant to the Stockholder Agreement and the RFMD Board Representation Agreement, and shall enter into an indemnification agreement with such designee in substantially the form of the Company's
indemnification agreements with Carlyle's and Conexant's designees under their respective Board Representation Agreements. 

        5.    Conditions to Closing.    

        5.1.    Conditions to RFMD's Obligations at the Closing.    The obligations of RFMD to purchase the Shares is subject
to the fulfillment at or prior to the Closing of the following conditions, any of which may be waived in whole or in part by RFMD unless otherwise required by state or federal law: 

        (a)    Representations and Warranties.    Each of the representations and warranties made by the Company in  Section 2 that is
qualified by materiality shall be true and correct, and each of such representations and warranties of the Company that is not
so qualified shall be true and correct in all material respects, as of the Closing Date, with the same force and effect as if they had been made on and as of the Closing Date. 

10

  

        (b)    Covenants.    All covenants, agreements, obligations and conditions contained in this Agreement to be performed
by the Company on or prior to the Closing Date shall have been performed or complied with in all material respects. 

        (c)    Consents.    The Company shall have obtained all material consents, permits and waivers necessary to consummate
the transactions contemplated by this Agreement and the Transaction Documents. 

        (d)    Reservation of Conversion Stock.    The shares of the Conversion Stock issuable upon conversion of the Shares
shall have been duly authorized and reserved for issuance upon such conversion. 

        (e)    Proceedings and Documents.    All corporate, legal, and other proceedings taken by the Company in connection
with the transactions contemplated hereby shall be reasonably satisfactory to RFMD. All documents to be delivered to RFMD by the Company pursuant to Section 1.2(c)  shall have been so delivered, and
RFMD shall have received all counterpart originals or certified or other copies of such documents as it may reasonably request. 

        (f)    Filing of Certificate.    The Certificate shall have been filed with the Secretary of State of the State of
Delaware. 

        (g)    Adverse Proceedings.    No suit, action or other proceeding seeking to restrain, prevent or change the
transactions contemplated hereby or by the Transaction Documents or otherwise questioning the validity or legality of such transactions shall have been instituted or be pending. 

        (h)    HSR Act Waiting Period.    All applicable HSR Act waiting periods, if any, together with any extensions
thereof, shall have expired or terminated. 

        5.2.    Conditions to Company's Obligations at the Closing.    The Company's obligation to sell and issue the Shares
at the Closing under this Agreement is subject to the fulfillment to the Company's satisfaction on or prior to the Closing Date of the following conditions, any of which may be waived in whole or in
part by the Company unless otherwise required by state or federal law: 

        (a)    Representations and Warranties.    Each of the representations and warranties made by RFMD in  Section 3 that is
qualified by materiality shall be true and correct, and each of such representations and warranties of RFMD that is not so
qualified shall be true and correct in all material respects, as of the Closing Date, with the same force and effect as if they had been made on and as of the Closing Date. 

        (b)    Covenants.    All covenants, agreements, obligations and conditions contained in this Agreement to be performed
by RFMD on or prior to the Closing Date shall have been performed or complied with in all material respects. 

        (c)    Consents.    RFMD shall have obtained all material consents, permits and waivers necessary to consummate the
transactions contemplated by this Agreement and the Transaction Documents. 

        (d)    Proceedings and Documents.    All corporate, legal, and other proceedings taken by RFMD in connection with the
transactions contemplated hereby shall be reasonably satisfactory to the Company. All documents to be delivered to the Company by RFMD pursuant to  Section 1.2(b) shall have been so delivered, and
the Company shall have received all counterpart originals or certified or other copies of such
documents as it may reasonably request. 

11

 

        (e)    Securities Law Compliance.    The offer and sale of the Shares pursuant to this Agreement shall be in
compliance with all federal securities laws and the securities laws of any applicable states as necessary to offer and sell the Shares to RFMD in compliance with all applicable laws. 

        (f)    Adverse Proceedings.    No suit, action or other proceeding seeking to restrain, prevent or change the
transactions contemplated hereby or by the Transaction Documents or otherwise questioning the validity or legality of such transactions shall have been instituted or be pending. 

        (g)    HSR Act Waiting Period.    All applicable HSR Act waiting periods, if any, together with any extensions
thereof, shall have expired or terminated. 

        6.    Indemnification.    

        6.1.    Indemnification by the Company.    The Company shall indemnify, defend and hold harmless RFMD and its
officers, directors and affiliates (the "RFMD Indemnitees") from, against and with respect to any
and all action or cause of action, loss, damage (including, without limitation, all foreseeable and unforeseeable consequential damages), claim, obligation, liability, penalty, fine, cost and expense
(including, without limitation, reasonable attorneys' and consultants' fees and costs and expenses incurred in investigating, preparing, defending against or prosecuting any litigation, claim,
proceeding, demand or request for action by any governmental or administrative entity), of any kind or character (a "Loss") arising out of or in
connection with any of the following: 

        (a)   any
breach of any of the representations or warranties of the Company contained in or made pursuant to this Agreement; and 

        (b)   any
failure by the Company to perform or observe, or to have performed or observed, in full, any covenant, agreement, obligation or condition to be performed or observed
by it pursuant to this Agreement; 

        6.2.    Indemnification by RFMD.    RFMD shall indemnify, defend and hold harmless the Company and its officers,
directors and affiliates (the "Company Indemnitees") from, against and with respect to any Loss arising out of or in connection with any of the
following: 

        (a)   any
breach of any of the representations and warranties of RFMD contained in or made pursuant to this Agreement; and 

        (b)   any
failure by RFMD to perform or observe, or to have performed or observed, in full, any covenant, agreement, obligation or condition to be performed or observed by it
pursuant to this Agreement. 

        6.3.    Notice of Claim.    Any party seeking to be indemnified hereunder (the "Indemnified
Party") shall promptly notify the party from whom indemnity is sought (the "Indemnity Obligor") in writing of any claim for
recovery, specifying in reasonable detail the nature of the Loss. The Indemnified Party shall provide to the Indemnity Obligor as promptly as practicable thereafter all information and documentation
reasonably requested by the Indemnity Obligor to verify the claim asserted. 

        6.4.    Defense.    If the facts pertaining to a Loss arise out of the claim of any third party, or if there is any
claim against a third party available by virtue of the circumstances of the Loss, the Indemnity Obligor may, by giving written notice to the Indemnified Party within 15 days following its
receipt of the notice of such claim, elect to assume control of the defense or the prosecution thereof, including the employment of counsel or accountants at its cost and expense. The Indemnity
Obligor shall be entitled (but not obligated), if it so elects, to compromise or settle such 

12

 

claim,
which compromise or settlement shall be made within the sole discretion of the Indemnity Obligor without the consent of the Indemnified Party if such settlement or compromise only involves the
payment of monetary amounts, but shall be made only with the written consent of the Indemnified Party, such consent not to be unreasonably withheld, if such settlement or compromise involves
obligations other than the payment of monetary amounts. The Indemnified Party shall have the right to employ counsel separate from counsel employed by the Indemnity Obligor in any such action and to
participate therein, but the fees and expenses of such counsel shall be at the Indemnified Party's own expense. Whether or not the Indemnity Obligor chooses to so defend or prosecute such claim, all
the parties hereto shall cooperate in the defense or prosecution thereof and shall furnish such records, information and testimony and shall attend such conferences, discovery proceedings and trials
as may be reasonably requested in connection therewith. 

        6.5.    Exclusive Remedy.    The foregoing indemnification provisions shall constitute the sole and exclusive remedy
of the Company and RFMD for any inaccuracy, untruth, incompleteness or other breach of any representation, warranty or covenant contained in or made by RFMD or the Company, as appropriate, pursuant to
this Agreement or in any certificates delivered at the Closing in connection with or related to the consummation of the Transactions contemplated by this Agreement. 

        6.6.    Limitations on Liability.    The maximum aggregate amount of Loss for which RFMD shall be liable shall be
limited to $6,000,000 and the maximum aggregate amount of Loss for which the Company shall be liable shall be limited to $6,000,000; provided that, with
respect to such claims, neither the RFMD Indemnities nor the Company Indemnities shall be entitled to be indemnified until the aggregate amount of their Loss arising out of such claims exceeds
$500,000. Once the aggregate amount of the RFMD Indemnitees' or the Company Indemnitees' Loss arising out of the foregoing claims exceeds $500,000, the Company Indemnitees or the RFMD Indemnitees, as
appropriate, shall be entitled to indemnification for all Loss incurred, including the first $500,000, up to the above limitations. Notwithstanding anything to the contrary herein, any Loss of RFMD
arising out of a breach of a representation, warranty or covenant that involves a Loss or diminution in value of the Company shall be limited to RFMD's pro rata portion of such Loss based upon RFMD's
proportionate ownership interest in the Company. 

        7.    Miscellaneous.    

        7.1.    Governing Law.    This Agreement shall be governed by and construed under the laws of the State of Delaware as
applied to agreements among Delaware residents, made and to be performed entirely within the State of Delaware. 

        7.2.    Survival.    The representations, warranties, covenants, and agreements made herein shall survive the Closing
of the transactions contemplated hereby until the earlier of (a) twelve (12) months from the Closing Date and (b) the consummation of the Company's initial public offering of its
common stock registered under the Securities Act of 1933, as amended. All statements as to factual matters contained in any certificate or other instrument delivered by or on behalf of the Company
pursuant hereto or in connection with the transactions contemplated hereby shall be deemed to be representations and warranties by the Company hereunder as of the date of such certificate or
instrument. 

        7.3.    Finder's Fee.    Each party represents that it neither is nor will be obligated for any finder's fee or
commission in connection with this transaction. Each of RFMD and the Company agree to indemnify and hold harmless each other party from any liability for any commission or compensation in the nature
of a finder's fee (and the costs and expenses of investigating and defending against such liability or asserted liability, including, without limitation, reasonable fees of counsel) for which RFMD or
the Company, as the case may be, is responsible. 

13

 

        7.4.    Successors and Assigns.    Except as otherwise expressly provided herein, the provisions hereof shall inure to
the benefit of, and be binding upon, the successors, assigns, heirs, executors, and administrators of the parties hereto. 

        7.5.    Entire Agreement.    This Agreement, the Exhibits hereto, the Transaction Documents and the other documents
delivered pursuant to this Agreement constitute the full and entire understanding and agreement among the parties with regard to the subjects hereof and thereof and no party shall be liable or bound
to any other party in any manner by any representations, warranties, covenants, or agreements except as specifically set forth herein or therein. Nothing in this Agreement, express or implied, is
intended to confer upon any party, other than the parties hereto and their respective successors, executors, administrators, heirs and assigns, any rights, remedies, obligations, or liabilities under
or by reason of this Agreement, except as expressly provided herein. 

        7.6.    Severability.    In case one or more provisions of this Agreement become or are declared by a court of
competent jurisdiction to be illegal, unenforceable or void, this Agreement shall continue in full force and effect without said provision or provisions; provided,
however, that no such severability shall be effective if it materially changes the economic benefit of this Agreement to any party. 

        7.7.    Amendment and Waiver.    Any term of this Agreement may be amended only with the written consent of the
Company and RFMD. 

        7.8.    Notices.    All notices required or permitted hereunder shall be in writing and shall be deemed effectively
given: (a) upon personal delivery to the party to be notified; (b) when sent by confirmed telex or facsimile if sent during normal business hours of the recipient, if not, then on the
next business day; (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (d) one (1) day after deposit
with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the Company or RFMD at the respective address as
set forth on the signature page hereof or at such other address as the Company or RFMD may designate by ten (10) days advance written notice to the other. 

        7.9.    Titles and Subtitles.    The titles of the sections of this Agreement are for convenience of reference only
and are not to be considered in construing this Agreement. 

        7.10.    Counterparts.    This Agreement may be executed in any number of counterparts, each of which shall be deemed
an original, but all of which together shall constitute one instrument. 

[Signature page follows] 

14

 

        IN
WITNESS WHEREOF, the parties have executed this Amended and Restated Preferred Stock Purchase Agreement as of the date first above written. 

	 	 	COMPANY
	 	 	 	 
	 	 	JAZZ SEMICONDUCTOR, INC.,

a Delaware corporation
	 	 	 	 
	 	 	 	 
	 	 	By:	/s/  SHU LI      
 Shu Li

President and Chief Executive Officer

	 	 	 	 
	 	 	Address:	4321 Jamboree Blvd.

Newport Beach, CA 92660
	 	 	Fax No.:	(949) 435-8455
	 	 	Attention:	Legal Counsel
	 	 	 	 
	 	 	With a copy to:
	 	 	 	 
	 	 	Latham & Watkins

650 Town Center Drive, 20th Floor

Costa Mesa, CA 92626

Attn: Jonn R. Beeson

Facsimile: (714) 755-8290

	 	 	 	 
	 	 	RFMD
	 	 	 	 
	 	 	RF MICRO DEVICES, INC.,

a North Carolina corporation
	 	 	 	 
	 	 	 	 
	 	 	By:	/s/  JERRY D. NEAL      
 Jerry D. Neal

Executive Vice President of Marketing &

Strategic Development

	 	 	 	 
	 	 	Address:	7628 Thorndike Road

Greensboro, NC 27409
	 	 	Fax No.:	(336) 931-7655
	 	 	Attention:	Suzanne Rudy
	 	 	 	 
	 	 	With a copy to:
	 	 	 	 
	 	 	Womble Carlyle Sandridge & Rice, PLLC

200 West Second Street

Winston-Salem, NC 27101

Attn: Jeffrey C. Howland, Esq.

Facsimile: (336) 733-8371

S-1

SCHEDULE 2.5(a)  

 STOCKHOLDERS  

	Classification of Stock
 
	 	Stockholder
	 	Number of Shares

Outstanding

	Series A Preferred	 	Carlyle Partners III, L.P.	 	50,254,440
	Series A Preferred	 	Carlyle High Yield Partners, L.P.	 	2,750,000
	Series A Preferred	 	CP III Coinvestment, L.P.	 	1,995,560
	

Series B Preferred	
 	

Conexant Systems, Inc.	
 	

45,000,000
	

Series A Common	
 	

 	
 	

no shares outstanding
	Series B Common	 	 	 	no shares outstanding
	

Total Options issued as of August 22, 2002	
 	

 	
 	

no more than 8,000,000

SCHEDULE 2.5(c)  

 COMPANY SUBSIDIARIES  

        Newport Fab, LLC—membership interest owned 100% by Jazz Semiconductor, Inc. 

SCHEDULE 2.7  

 FINANCIAL STATEMENTS  

[...***...]

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

SCHEDULE 2.9  

 MATERIAL LITIGATION  

[...***...] 

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

SCHEDULE 2.10  

 CHANGES SINCE STATEMENT DATE  

 [SEE ATTACHED]  

[...***...]

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

SCHEDULE 2.11  

 PROPRIETARY ASSETS  

[...***...] 

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

SCHEDULE 2.15  

 ARRANGEMENTS WITH CONEXANT  

[...***...]

Confidential
treatment has been requested for portions of this document. This copy of the document filed as an Exhibit omits the confidential information subject to the confidentiality request.
Omissions are designated by the symbol [...***...]. A complete version of this document has been filed separately with the Securities and Exchange Commission. 

QuickLinks

AMENDED AND RESTATED PREFERRED STOCK PURCHASE AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00060-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00060-of-00352.parquet"}]]